Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EONS 8 /
Long term survival with testicular cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.05.12
Views: 5157
Rating:

Sophie Bunskoek – University Medical Center Gronigen, The Netherlands

At the European Oncology Nursing Society annual meeting in Geneva, April 2012, Sophie Bunskoek talked to ecancertv about the concerns for prostate cancer patients and their long-term survival.

 

The main side effects of chemotherapy with prostate cancer patients in the long term are toxicity after treatment and cardiovascular problems. To combat this patients are frequently checked for cardiovascular disease through frequent follow-ups.

 

Psychological effects also appear in patients; these can be financial worries, sexual side effects such as infertility, and fear of recurrence.

 

Ms Bunskoek and University Medical Center Gronigen aim to confront these problems through a new App that can be used in conjunction with follow ups with a GP instead of frequently visiting the hospital.

 

Filming Supported by Amgen

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation